Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-038714
Filing Date
2025-04-24
Accepted
2025-04-24 16:45:29
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-24

Document Format Files

Seq Description Document Type Size
1 ARS tm2512723d1_ars.pdf ARS 12140305
  Complete submission text file 0001104659-25-038714.txt   16720183
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37939 | Film No.: 25868270
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)